Sarepta Therapeutics
Price & Volume
Stats
See more52W Range | $10.41-$107.77 |
Market Cap | $1.9B |
Shares Short | 22M |
Financials
See moreRevenue (12 Mos) | $2.4B |
Revenue Growth (YoY) | -14.5% |
Gross Profit (12 Mos) | $443.8M |
Diluted EPS | -$2.83 |
News
See moreYahoo Finance • 2 days ago
Sarepta Therapeutics Inc (SRPT) Q4 2025 Earnings Call Highlights: Strong Financial Position ...
Yahoo Finance • 2 days ago
Sarepta (SRPT) Q4 2025 Earnings Call Transcript
Yahoo Finance • 18 days ago
Global Gene Therapy and CRISPR Market Shows Billion Dollar Growth with Novartis Zolgensma 1.2 Billion Sarepta Elevidys 611 Million and Emerging CRISPR Collaborations 20 Million
Yahoo Finance • 22 days ago
Arrowhead Pharmaceuticals Inc (ARWR) Q1 2026 Earnings Call Highlights: Strong Financial ...
About
CEO | Mr. Douglas S. Ingram Esq., J.D. |
CFO | Ryan H. Wong |
Address | 215 First Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1,372 |
